Kite Pharma

Ex-Kite chiefs’ biotech to research ‘off-the-shelf’ CAR-Ts with Cellectis

https://pharmaphorum.com/news/ex-kite-chiefs-biotech-research-off-shelf-car-ts-cellectis/

Gilead completes $11.9bn Kite acquisition

https://pharmaphorum.com/news/gilead-kite-acquisition/

Novartis’ CAR-T drug needs new payment model, says Express Scripts

https://pharmaphorum.com/news/novartis-car-t-expensive-us-health-system-express-scripts/

Gilead swoops to buy Kite for $12billion

https://pharmaphorum.com/news/gilead-swoops-buy-kite-12billion/

Real world data essential for CAR-T therapy success

https://pharmaphorum.com/news/real-world-data-car-t/

Scottish firm gets EU funding for ‘off the shelf’ cancer cell therapy

https://pharmaphorum.com/news/tcb-funding-off-shelf-cancer-therapy/

Kite files CAR-T therapy in EU, ahead of Novartis rival

https://pharmaphorum.com/news/kite-car-t-novartis/

New 3-year data supports Kite ‘cure’ hopes for CAR-T

https://pharmaphorum.com/news/new-3-year-data-supports-kite-cure-hopes-car-t/

Novartis close to first-ever CAR-T approval after unanimous vote

https://pharmaphorum.com/news/novartis-car-t-ctl019-backed-fda-advisers/

1 2 3

Close in 10 seconds

Pharmaphorum.com

Search